Synapse - Vanessa Ryan Thompson

Vanessa Ryan Thompson

Research Focus

Former Employee. Research Facilities; GLP & Quality Assurance Manager (Antitumor Assessment)

Recent additions – View all

A phase 1b multi-center study of the FLT3 inhibitor gilteritinib in combination with the IDH1 inhibitor ivosidenib or the IDH2 inhibitor enasidenib for patients with relapsed or refractory acute myeloid leukemia who have co-occurring FLT3/IDH1 or FLT3/IDH2 mutations
Meeting Abstract

Stein, E. M.; Derkach, A.; Melamed, G.; Block, A.; Kim, J.; Georgieva, G.; Thompson, V.; Levine, R. L.; Intlekofer, A. M.; Abdel-Wahab, O.; more...
Blood (2023)

Fulltext@MSK | Save
Kidney-targeted redox scavenger therapy prevents cisplatin-induced acute kidney injury
Journal Article

Williams, R. M.; Shah, J.; Mercer, E.; Tian, H. S.; Thompson, V.; Cheung, J. M.; Dorso, M.; Kubala, J. M.; Gudas, L. J.; de Stanchina, E.; more...
Frontiers in Pharmacology (2022)

Fulltext@MSK | Save
Phase I study of transarterial chemoembolization of lung metastases
Meeting Abstract

Boas, F. E.; Kemeny, N. E.; Sofocleous, C. T.; Yeh, R.; Thompson, V. R.; Hsu, M.; Moskowitz, C. S.; Ziv, E.; Yarmohammadi, H.; Bendet, A.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Co-authors at MSK

2

Bendet
2

Boas
2

Hsu
2

Kemeny
2

Moskowitz
2

Sofocleous
2

Solomon
2

Yarmoha...
2

Yeh
2

Ziv
1

Abdel-W...
1

Cheung
1

De Stan...
1

Derkach
1

Dorso
1

Heller
1

Intlekofer
1

Jaimes
1

Kubala
1

Levine
1

Melamed
1

Mercer
1

Shah
1

Stein
1

Tian
1

Williams

Types of Work

Publications